NICHOLAS TRUDO: Open Payments
NPI 1467938290 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,563 in 140 payments from 31 companies in 2025. Trend: 2023 $122 · 2024 $3,065 · 2025 $3,563
Food & beverage: $3,563
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 14 | $500 |
| Novo Nordisk Inc | 15 | $284 |
| Dexcom, Inc. | 3 | $238 |
| BETA BIONICS, INC. | 7 | $235 |
| Xeris Pharmaceuticals, Inc. | 10 | $195 |
| SANOFI-AVENTIS U.S. LLC | 5 | $194 |
| Corcept Therapeutics | 14 | $188 |
| Lilly USA, LLC | 7 | $161 |
| Amgen Inc. | 10 | $161 |
| RGH Enterprises LLC | 1 | $142 |
Products named: Omnipod, iLet Bionic Pancreas, TZIELD, Korlym, DEXCOM G7 GSS (161), RECORLEV, Veozah, MOUNJARO.
Industry payments across SC — which companies pay providers there.
